About Exactics
Exactics is a Chicago-based startup developing diagnostic tools for underrepresented infectious diseases. Our mission is to expedite at-home and clinical diagnoses, leading to improved treatment plans and long-term health outcomes.
Our Story
After witnessing his childhood best friend suffer from Lyme disease for months without diagnosis or treatment, Julian Kage, Founder & CEO of Exactics, began researching why so many patients experience delayed diagnosis and long-term complications. That experience inspired him to develop a novel rapid diagnostic solution to make early detection faster, easier, and more accessible.
Once he started at the University of Chicago, Julian gathered his best friends with experience in biology, business, and technology to help him turn his vision for Exactics into a reality.- 2017: Developed diagnostic technology for early disease detection.
- 2021: Founded Exactics for revolutionizing rapid diganostics.
- 2023: Built a co-founding team from University of Chicago & Tulane.
Our Vision
At Exactics, we envision a world where no one suffers due to the lack of accessible, accurate, and timely diagnostic testing. Early detection is the key to preventing the devastating effects of infectious diseases.
By leveraging our patented technology, strategic research partnerships, and innovative test development, we aim to eliminate diagnostic delays and make life-saving tools available anytime, anywhere.
Currently, 95% of the WHO’s priority pathogens lack adequate rapid diagnostics. Of the millions of annual deaths from infectious diseases, 70% could be prevented with earlier detection and treatment. Our mission is to bridge this gap — expanding beyond Lyme disease to build a global network of rapid tests that empower patients, healthcare providers, and public health systems.
Ultimately, our goal is to make rapid diagnostics as universal and accessible as pregnancy or COVID tests — ensuring that early detection becomes a standard in healthcare, not a privilege.
Julian Kage
Chief Executive Officer
Dylan Murray
Chief Operating Officer
Zachary Sarmoen
Chief Financial Officer
Maxwell Almeida
Chief Technology Officer
Sean Greeby
Chief Scientific Officer
Miranda Thomson
Business Intern
John Trevino
Research Intern
Dylan Martin
Development Intern
Devin Singh
Logistics Intern
Karena Peterson
Marketing & Research Intern
Advisory Board
Our advisory board features former biotech CEOs, venture capital leaders, and top academics from institutions like Harvard, Cambridge, and Chicago Booth — bringing decades of experience in diagnostics, fundraising, and scaling early-stage ventures.